Literature DB >> 30867580

Host tissue determinants of tumour immunity.

Hélène Salmon1,2,3, Romain Remark4, Sacha Gnjatic5,6,7, Miriam Merad8,9.   

Abstract

Although common evolutionary principles drive the growth of cancer cells regardless of the tissue of origin, the microenvironment in which tumours arise substantially differs across various organ sites. Recent studies have established that, in addition to cell-intrinsic effects, tumour growth regulation also depends on local cues driven by tissue environmental factors. In this Review, we discuss how tissue-specific determinants might influence tumour development and argue that unravelling the tissue-specific contribution to tumour immunity should help the development of precise immunotherapeutic strategies for patients with cancer.

Entities:  

Mesh:

Year:  2019        PMID: 30867580      PMCID: PMC7787168          DOI: 10.1038/s41568-019-0125-9

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  217 in total

1.  Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Authors:  Sachet A Shukla; Pavan Bachireddy; Bastian Schilling; Christina Galonska; Qian Zhan; Clyde Bango; Rupert Langer; Patrick C Lee; Daniel Gusenleitner; Derin B Keskin; Mehrtash Babadi; Arman Mohammad; Andreas Gnirke; Kendell Clement; Zachary J Cartun; Eliezer M Van Allen; Diana Miao; Ying Huang; Alexandra Snyder; Taha Merghoub; Jedd D Wolchok; Levi A Garraway; Alexander Meissner; Jeffrey S Weber; Nir Hacohen; Donna Neuberg; Patrick R Potts; George F Murphy; Christine G Lian; Dirk Schadendorf; F Stephen Hodi; Catherine J Wu
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

2.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

3.  Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Authors:  Hui Peng; Xiaojun Jiang; Yonglin Chen; Dorothy K Sojka; Haiming Wei; Xiang Gao; Rui Sun; Wayne M Yokoyama; Zhigang Tian
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

4.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

5.  Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.

Authors:  Tatjana Marinkovic; Alexandre Garin; Yoshifumi Yokota; Yang-Xin Fu; Nancy H Ruddle; Glaucia C Furtado; Sergio A Lira
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

6.  Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis.

Authors:  Miseon Lee; Sun-Hee Heo; In Hye Song; Hajar Rajayi; Hye Seon Park; In Ah Park; Young-Ae Kim; Heejae Lee; Gyungyub Gong; Hee Jin Lee
Journal:  Mod Pathol       Date:  2018-08-28       Impact factor: 7.842

7.  Autonomic nerve development contributes to prostate cancer progression.

Authors:  Claire Magnon; Simon J Hall; Juan Lin; Xiaonan Xue; Leah Gerber; Stephen J Freedland; Paul S Frenette
Journal:  Science       Date:  2013-07-12       Impact factor: 47.728

8.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Authors:  Ainhoa Arina; Christian Idel; Elizabeth M Hyjek; Maria-Luisa Alegre; Ying Wang; Vytautas P Bindokas; Ralph R Weichselbaum; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-17       Impact factor: 11.205

9.  Neutrophils dominate the immune cell composition in non-small cell lung cancer.

Authors:  Julia Kargl; Stephanie E Busch; Grace H Y Yang; Kyoung-Hee Kim; Mark L Hanke; Heather E Metz; Jesse J Hubbard; Sylvia M Lee; David K Madtes; Martin W McIntosh; A McGarry Houghton
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

10.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

View more
  72 in total

Review 1.  How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy.

Authors:  Jinyang Li; Ben Z Stanger
Journal:  Cancer Res       Date:  2020-06-18       Impact factor: 12.701

2.  Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors.

Authors:  Jang Hyun Park; Hyun-Jin Kim; Chae Won Kim; Hyeon Cheol Kim; Yujin Jung; Hyun-Soo Lee; Yunah Lee; Young Seok Ju; Ji Eun Oh; Sung-Hong Park; Jeong Ho Lee; Sung Ki Lee; Heung Kyu Lee
Journal:  Nat Immunol       Date:  2021-02-11       Impact factor: 25.606

Review 3.  The cancer-natural killer cell immunity cycle.

Authors:  Nicholas D Huntington; Joseph Cursons; Jai Rautela
Journal:  Nat Rev Cancer       Date:  2020-06-24       Impact factor: 60.716

Review 4.  Not all cancers are created equal: Tissue specificity in cancer genes and pathways.

Authors:  Joy J Bianchi; Xin Zhao; Joseph C Mays; Teresa Davoli
Journal:  Curr Opin Cell Biol       Date:  2020-02-21       Impact factor: 8.382

5.  Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.

Authors:  Samarth Hegde; Varintra E Krisnawan; Brett H Herzog; Chong Zuo; Marcus A Breden; Brett L Knolhoff; Graham D Hogg; Jack P Tang; John M Baer; Cedric Mpoy; Kyung Bae Lee; Katherine A Alexander; Buck E Rogers; Kenneth M Murphy; William G Hawkins; Ryan C Fields; Carl J DeSelm; Julie K Schwarz; David G DeNardo
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

6.  Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma.

Authors:  Tetsushi Murakami; Nobuyuki Tanaka; Kimiharu Takamatsu; Kyohei Hakozaki; Keishiro Fukumoto; Tsukasa Masuda; Shuji Mikami; Toshiaki Shinojima; Kazuhiro Kakimi; Tatsuhiko Tsunoda; Kazuaki Sawada; Takeshi Imamura; Ryuichi Mizuno; Mototsugu Oya
Journal:  Cancer Immunol Immunother       Date:  2021-07-14       Impact factor: 6.968

Review 7.  Nerves in cancer.

Authors:  Ali H Zahalka; Paul S Frenette
Journal:  Nat Rev Cancer       Date:  2020-01-23       Impact factor: 60.716

8.  Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade.

Authors:  Sneha Berry; Nicolas A Giraldo; Benjamin F Green; Alexander S Szalay; Janis M Taube; Tricia R Cottrell; Julie E Stein; Elizabeth L Engle; Haiying Xu; Aleksandra Ogurtsova; Charles Roberts; Daphne Wang; Peter Nguyen; Qingfeng Zhu; Sigfredo Soto-Diaz; Jose Loyola; Inbal B Sander; Pok Fai Wong; Shlomit Jessel; Joshua Doyle; Danielle Signer; Richard Wilton; Jeffrey S Roskes; Margaret Eminizer; Seyoun Park; Joel C Sunshine; Elizabeth M Jaffee; Alexander Baras; Angelo M De Marzo; Suzanne L Topalian; Harriet Kluger; Leslie Cope; Evan J Lipson; Ludmila Danilova; Robert A Anders; David L Rimm; Drew M Pardoll
Journal:  Science       Date:  2021-06-11       Impact factor: 47.728

9.  Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.

Authors:  Marcus Ruscetti; John P Morris; Riccardo Mezzadra; James Russell; Josef Leibold; Paul B Romesser; Janelle Simon; Amanda Kulick; Yu-Jui Ho; Myles Fennell; Jinyang Li; Robert J Norgard; John E Wilkinson; Direna Alonso-Curbelo; Ramya Sridharan; Daniel A Heller; Elisa de Stanchina; Ben Z Stanger; Charles J Sherr; Scott W Lowe
Journal:  Cell       Date:  2020-03-31       Impact factor: 41.582

10.  Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming.

Authors:  Mark S Diamond; Jeffrey H Lin; Robert H Vonderheide
Journal:  Cancer Immunol Res       Date:  2021-06-18       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.